Clinical Trials for Hemophagocytic Lymphohistiocytosis

Find clinical trials for hemophagocytic lymphohistiocytosis. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT ID: NCT01793168

The Coordination of Rare Diseases at Sanford (CoRDS) is a clinical trial aimed at creating a large, centralized registry for individuals affected by rare diseases. This registry helps connect patie...

Recruiting

Type: observational Locations: Sioux Falls, South Dakota, United States, Sydney, , Australia

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

NCT ID: NCT01652092

This clinical trial is looking at a treatment called allogeneic hematopoietic stem cell transplant (HSCT) for patients with certain primary immune deficiencies. These are conditions where the immun...

Recruiting

Phase: NA Type: interventional Locations: Minneapolis, Minnesota, United States

Immune Disorder HSCT Protocol

NCT ID: NCT01821781

This clinical trial is studying a new treatment approach for patients with certain immune deficiency disorders, which are conditions where the immune system does not work properly. The goal is to s...

Recruiting

Phase: PHASE2 Type: interventional Locations: Saint Louis, Missouri, United States

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

NCT ID: NCT06131489

This clinical trial is exploring a treatment approach for patients with a rare and serious condition called Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis (EBV-HLH), particularly ...

Not yet recruiting

Type: observational Locations: Beijing, Beijing, China

GTP Regimen in the Treatment of Refractory/Recurrent HLH

NCT ID: NCT06038422

This clinical trial is looking at a treatment called the GTP regimen for patients with refractory or recurrent hemophagocytic lymphohistiocytosis (HLH), a serious condition that causes the immune s...

Not yet recruiting

Phase: PHASE3 Type: interventional

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

NCT ID: NCT05775705

This clinical trial is studying a new treatment approach for patients with a rare condition called Epstein-Barr virus-positive lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH). The t...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, Beijing, China

Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH

NCT ID: NCT05546060

This clinical trial is studying a combination of three medications—venetoclax, dexamethasone, and etoposide—to see how well they work and how safe they are for treating hemophagocytic lymphohistioc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH

NCT ID: NCT05315336

This clinical trial is designed to test a new treatment combination for patients with a serious condition called Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH), which ca...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions